Extragonadal germinoma

Extragonadal germinoma is a rare malignant germ cell tumor that arises outside the gonads (ovaries and testes), developing instead in midline locations of the body. These tumors are histologically identical to gonadal germinomas (also called seminomas in the testis or dysgerminomas in the ovary) but occur in extragonadal sites such as the mediastinum (central chest), retroperitoneum (behind the abdominal cavity), and the central nervous system (particularly the pineal and suprasellar regions of the brain). The ICD-10 codes associated with this condition reflect these diverse anatomical locations (C38.3 for mediastinum, C48.8 for retroperitoneum, C72.9 for central nervous system). Extragonadal germinomas are thought to arise from primordial germ cells that failed to migrate properly to the gonads during embryonic development. Clinical presentation varies depending on the tumor location. Mediastinal germinomas may cause chest pain, cough, shortness of breath, and superior vena cava syndrome. Intracranial germinomas frequently present with headaches, visual disturbances, diabetes insipidus (excessive thirst and urination due to pituitary involvement), hormonal imbalances including delayed or precocious puberty, and signs of increased intracranial pressure. Retroperitoneal tumors may cause abdominal pain, a palpable mass, or compression of surrounding structures. The condition predominantly affects children, adolescents, and young adults, with a male predominance particularly for mediastinal and intracranial locations. Extragonadal germinomas are generally highly sensitive to both radiation therapy and platinum-based chemotherapy, which forms the cornerstone of treatment. Intracranial germinomas in particular have excellent cure rates exceeding 90% with appropriate combined chemoradiation protocols. Treatment strategies typically involve a combination of chemotherapy (often cisplatin or carboplatin-based regimens) followed by involved-field radiation therapy. Surgical resection may play a role depending on tumor location and accessibility. Serum and cerebrospinal fluid tumor markers, including beta-human chorionic gonadotropin (beta-hCG) and alpha-fetoprotein (AFP), are important for diagnosis and monitoring treatment response. Prognosis is generally favorable compared to other malignant germ cell tumor subtypes, though outcomes depend on tumor location, extent of disease, and response to initial therapy.

Common questions about Extragonadal germinoma